CURE looks back on some of the most important stories in the chronic lymphocytic leukemia space from 2023. In honor of September being blood cancer awareness month, we took a look at five noteworthy ...
Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated ...
Chronic lymphocytic leukemia (CLL), is a type of cancer that affects a type of white blood cell in your body called a lymphocyte. White blood cells are made in your bone marrow and help your body ...
Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) are types of slow-growing cancers that affect a type of white blood cell called a lymphocyte. Lymphocytes are cells that help ...
An expert provided an overview of the promising therapies that are being investigated for the treatment of patients with chronic lymphocytic leukemia. There are many new agents being investigated for ...
Which Is the Best Tyrosine Kinase Inhibitor for Newly Diagnosed Chronic Myelogenous Leukemia? Chronic lymphocytic leukemia (CLL) remains an incurable disease, except in rare cases treated with ...
The AMPLIFY study [NCT03836261] did not include patients with del (17p), so that doublet is not relevant. The study that used ...
Researchers of a new study explore what areas of chronic lymphocytic leukemia (CLL) treatment and care are important to patients and identify key areas for improvement. The research, completed in ...
These investigators assessed the poorly understood biology and genetics that underlie the transformation of CLL to RS and that impedes progress against this aggressive malignancy. TP53 Abnormalities ...
Chronic lymphocytic leukemia (CLL) is a type of blood cancer that causes your bone marrow to make too many of a type of white blood cells called lymphocytes. Unlike other types of leukemia, it’s a ...
CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group, which services over a million patients, survivors and caregivers across an industry-leading multi-channel platform devoted solely to cancer updates, ...